— Know what they know.
Not Investment Advice
Also trades as: LUCYW (NASDAQ) · $vol 0M

LUCY NASDAQ

Lucyd, Inc
1W: -6.1% 1M: -5.2% 3M: -28.1% YTD: -21.8% 1Y: -54.5% 3Y: -92.3%
$0.89
-0.03 (-3.14%)
 
Weekly Expected Move ±6.6%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Medical - Instruments & Supplies · Tech Score Buy · Power 49 · $5.6M mcap · 6M float · 77.14% daily turnover · Short 41% of daily vol

Income Trends

Revenue
$3M +62.6% ▲
5Y CAGR: +115.7%
Gross Profit
$567K +163.7% ▲
Operating Income
-$8M -7.2% ▼
Net Income
-$8M +2.3% ▲
EPS (Diluted)
$-1.90 +63.4% ▲
EBITDA
-$8M -9.7% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$691K$660K$1M$2M$3M
YoY Growth+1111.8%-4.5%+74.7%+42.0%+62.6%
Cost of Revenue$542K$716K$1M$1M$2M
Gross Profit$148K-$56K-$119K$215K$567K
Gross Margin21.5%-8.5%-10.4%13.1%21.3%
R&D Expenses$86K$525K$662K$819K$725M
SG&A Expenses$3M$5M$6M$7M$2.3B
Operating Expenses$3M$6M$7M$8M$9M
Operating Income-$3M-$6M-$7M-$8M-$8M
Operating Margin-464.1%-845.2%-594.9%-484.2%-319.2%
Interest Expense$39K$105K$3K$0$0
Income Before Tax-$3M-$6M-$7M-$8M-$8M
Tax Expense$0$0$0$0$0
Net Income-$3M-$6M-$7M-$8M-$8M
Net Margin-469.8%-861.2%-578.2%-474.6%-285.2%
EPS (Diluted)$-12.37$-17.41$-12.67$-5.19$-1.90
EBITDA-$3M-$6M-$7M-$8M-$8M
Shares Outstanding2622813264485258001M4M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms